Following over a decade of collaboration, the PSCI celebrates continued growth in Membership, record audit sharing, and increased reach in Asia to strengthen responsible practices across the pharmaceutical and healthcare value chain.

Read the report here.

The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2025 Annual Report, celebrating continued growth in Membership, record audit sharing, and increased reach in Asia. The PSCI held its first Member Meeting in Shanghai, China, and celebrated 10 years of the India Supplier Conference alongside the delivery of four technical workshops across the sub-continent. These efforts aim to ensure continued progress towards responsible supply chain practices in key sourcing regions for the industry.

The PSCI is powered by 81 Members who represent 70% of the pharma industry and more than $1.2tn revenue collectively. It exists to advance and embed responsible practices in the pharmaceutical, life science, and healthcare supply chains. The PSCI’s Members work together to uphold the PSCI Principles for Responsible Supply Chain Management and collaborate through the association’s strategic focus on Audits, Capability-building, and Projects.

Reflecting on the previous year, the 2025 PSCI Annual Report reached significant milestones in the journey to embed responsible practices in the pharmaceutical value chain.

• 1st member meeting held in China
• 297 audits uploaded in 2025, with 1,505 in total on the PSCI platform
• 10 new Supplier Partners recognized for their commitment to responsible practices, bringing the total number to 22
• 2,046 audit findings analyzed for insights into responsible supply chain issues and trends
• 1,377 attendees to the first-ever Decarbonization Summit from 807 companies
• 1,900+ attendees to 20 webinars, the largest audience to date
• 300+ individual attendees at the 10th anniversary of the PSCI Supplier Conference in India

Rob Williams, 2025 PSCI Chair says,

2025 was another impactful year for the PSCI. We grew our presence key sourcing locations throughout Asia and delivered a first-ever Decarbonization Summit to bring the industry together to make practical decarbonization a reality. The audits on our platform continue to grow and our annual analysis of findings provides deep insight into responsible supply chain issues and regional trends in key sourcing locations around the world. Celebrating 10 years of the India Supplier Conference and reaching an even greater number of suppliers through regional technical workshop shows the breadth and depth of our work; and our first-ever Japanese webinar on PiE/AMR was a fantastic contribution towards expanding our support for the Japanese market. The PSCI Membership is truly building responsible supply chains.

Japan is Asia’s engine for advanced drug discovery, a global leader in innovation, quality, and regulatory excellence. As the world’s third-largest pharma market, it’s home to groundbreaking R&D, high production standards, and unmatched trust in healthcare.

PSCI Members Wenjia Xu and Kozo Ohashi will be presenting on the Threat of AMR and Pharmaceutical Responsibility: Industry-Wide Initiatives and SHIONOGI Group Actions.

This presentation follows on from the successful webinar on this subject that took place in December 2025. Additional information about the PSCI and our mission and vision will also be presented.

The presentation will take place on 21 April. To register for the session, click here.

About CPHI Japan
CPHI Japan provides connections to the thriving ecosystem and access to the companies, insights, and opportunities shaping the future of pharmaceuticals across Asia Pacific.

The PSCI Principles for Responsible Supply Chain Management are our blueprint for responsible practice across the pharmaceutical and healthcare supply chain – and we are now inviting external stakeholders to provide input to our latest round of updates.

About the Principles

• First agreed by PSCI’s founding members in 2006
• Updated in 2019 and 2022
• All PSCI members commit to upholding the Principles, and they are widely referenced in supplier codes and public reporting

The Principles sit above individual supplier codes, setting high‑level expectations and encouraging members and suppliers to consider and respond to these topics within their own practices. They are designed to:

• Encourage continuous improvement across supply chains
• Remain relevant across a three‑year review cycle
• Be applicable across our diverse, global membership

With this in mind, our challenge is finding the right level of stretch: continuing to drive progress toward PSCI’s vision of responsible supply chains, while ensuring the Principles remain achievable and universal.

We are now inviting external stakeholders to contribute to this update through our consultation survey

To maintain a substantial amount of consistency in the Principles, we ask that suggestions focus on up to one significant and up to three minor changes.
Further details on the process and timeline can be found here

The deadline for feedback is 8 April, and the final updated Principles will be published in December 2026.

We look forward to hearing your perspectives and shaping the next evolution of the PSCI Principles together.

Anne-Laure Demarcy, Head of Environmental Sustainability at UCB, will join the Board in a non-voting, one-year guest position, supporting a diversity of perspective in the PSCI's governance.

Speaking of her appointment Anne-Laure says,

I see this guest Board position as an opportunity to contribute meaningfully to the PSCI's mission, while bringing a diverse and pragmatic perspective.

Please join us in congratulating Anne-Laure on her appointment.

About the guest role
2026 PSCI Chair, Lucy Latham is expecting her second child in spring and
in accordance with the PSCI Bylaws, the Vice Chair and Chair will jointly cover the Chair role during Lucy’s absence. We thank Rob Williams and Peter Nestor for their support in this matter.

The PSCI Board agreed to open up one temporary guest position on the Board, in a non-voting role, intended to maintain diversity of perspective in PSCI’s governance, for a period of 12 months or until the Chair's return.